Comparison of BCG with other intravesical agents.
Lamm
D L
DL
Department of Urology, West Virginia University Health Sciences Center, Morgantown.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001500:BCG Vaccine / Q000009:adverse effects / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000628:therapy; D003365:Costs and Cost Analysis; D006801:Humans; D015552:Injections, Intralesional; D015201:Meta-Analysis as Topic; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000628:therapy*
D000970:Antineoplastic Agents; D001500:BCG Vaccine